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The Use of Platelet Rich Fibrin in Pulpal and Periodontal Regeneration 
Elisabeth L. Easley, D.M.D., M.P.H. 
University of Nebraska, 2016  
Advisor: Joseph B. Bavitz, D.M.D. 
Purpose: Platelet rich fibrin (PRF) has been postulated to aid in regeneration. Therefore, the 
purpose of this study is to evaluate the inflammatory response of PRF in vitro, and analyze 
clinically and histologically the effectiveness of PRF on pulpal regeneration after reimplantation.  
Materials and Methods: The in vivo experiment included 18 patients (69 teeth). Teeth were 
extracted and apicoectomy performed. The tooth was reimplanted and splinted after PRF was 
condensed into the apex. Control teeth received the same treatment with the exception of the 
PRF. After 3-11 months, vitality was checked, teeth were extracted and analyzed histologically.  
For the in vitro, PRF was fabricated from two donors. A periodontal ligament (PDL) cell 
line was divided into four groups: A: PDL cells and PRF, B: PDL cells, PRF, and 
Lipopolysaccharide (LPS), C: PDL cells and LPS, and D: PDL cells only. After 24 h LPS was 
added to groups B and C. Supernatants were collected at 24, 48 and 72 h and an enzyme-linked 
immunosorbent assay was used to measure the concentration of IL-6. 
Results: PRF had no effect on diagnostic tests or histological outcome. Out of mouth time lead to 
more post-operative non-vital responses. For the cell cultures, PRF synergized with LPS inducing 
higher IL-6 release.  
Conclusions: PRF does not improve vitality responses in vivo and results in higher expression of 
IL-6 from PDLs.   
  
v 
 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS ................................................................................................................ i 
ABSTRACT .................................................................................................................................... iv 
TABLE OF CONTENTS ................................................................................................................. v 
LIST OF FIGURES ....................................................................................................................... vii 
LIST OF TABLES ........................................................................................................................ viii 
LIST OF ABBREVIATIONS ......................................................................................................... ix 
CHAPTER 1: INTRODUCTION .................................................................................................... 1 
CHAPTER 2: LITERATURE REVIEW ......................................................................................... 3 
CHAPTER 3: METHODS AND MATERIALS ........................................................................... 20 
Clinical Trial ..................................................................................................................... 20 
Investigator calibration  ...................................................................................... 20 
Study population and design ................................................................................ 20 
Baseline evaluations  ........................................................................................... 22 
PRF preparation  ................................................................................................. 22 
Surgical protocol and root preparation  .............................................................. 24 
Application of PRF  ............................................................................................. 24 
Follow up ............................................................................................................. 26 
Histological analysis ........................................................................................... 26 
In vitro Evaluation of IL-6 ................................................................................................ 29 
Study design: group designation and cell culture technique  .............................. 29 
Study design: procedure ...................................................................................... 31 
Cytokine expression analysis ............................................................................... 33 
Analysis of IL-6 expression in PRF membrane  ................................................... 36 
Statistical Analysis  ........................................................................................................... 36 
 
vi 
 
CHAPTER 4: RESULTS ............................................................................................................... 38 
Clinical Trial ..................................................................................................................... 38 
Patient characteristics  ........................................................................................ 38 
Clinical outcomes: ............................................................................................... 39 
Diagnostic test: EPT  ........................................................................................... 40 
Diagnostic test: thermal ....................................................................................... 42 
Diagnostic test: percussion  ................................................................................. 44 
Histological outcomes: ..................................................................................................... 46 
Comparison of histological grading  ................................................................... 46 
Healthy control teeth from patients not receiving study interventions ................ 48 
Descriptive histological results for teeth w/out PRF & teeth w/ PRF ................. 50 
Statistical analysis of histological results and clinical diagnostic tests  ............. 53 
In Vitro Analysis of IL-6 and PRF Outcomes .................................................................. 53 
CHAPTER 5: DISCUSSION ......................................................................................................... 61 
CHAPTER 6: CONCLUSIONS  ................................................................................................... 71 
BIBLIOGRAPHY .......................................................................................................................... 72 
Appendix A: IRB consent form  .................................................................................................... 78 
Appendix B: pg/ml concentrations of 24-72 hour collections ....................................................... 88 
Appendix C: Standard curve with R value .................................................................................... 89 
Appendix D: Patient demographics  .............................................................................................. 90 
Appendix E: Diagnostic tests pre- and post- patients 1-9 .............................................................. 91 
Appendix F: Diagnostic tests pre- and post- patients 10-18 .......................................................... 92 
Appendix G: Histological grading patients 1-9 ............................................................................. 93 
Appendix H: Histological grading patients 10-18 ......................................................................... 94 
 
vii 
 
LIST OF FIGURES 
Figure 1: PRF Layers After Centrifugation  .................................................................................... 7 
Figure 2: Flow of Clinical Study Design  ...................................................................................... 21 
Figure 3: Fabrication and preparation of PRF  .............................................................................. 23 
Figure 4: Apicoectomy, placement of PRF, and reimplantation with placement of splint  ........... 25 
Figure 5: PRF membrane with PDL cell adherence  ..................................................................... 30 
Figure 6: PRF membranes in culture medium  .............................................................................. 32 
Figure 7: ELISA samples demonstrating IL-6 identification  ........................................................ 35 
Figure 8: Changes in EPT over time by group  .............................................................................. 41 
Figure 9: Changes in thermal over time by group  ........................................................................ 43 
Figure 10: Changes in percussion proportion positive over time by group  .................................. 45 
Figure 11: Example of vital pulp from a healthy freshly extracted tooth not having received study 
interventions (10x) ......................................................................................................................... 49 
Figure 12: Histological images of teeth not treated with PRF (Control) representative of a sample 
of n=34 ........................................................................................................................................... 51 
Figure 13: Histological images of teeth treated with PRF (Test) representative of a sample of 
n=35 ............................................................................................................................................... 52 
Figure 14: 24-hour mean pg/ml concentrations PDL cells  ........................................................... 55 
Figure 15: 48-hour mean pg/ml concentrations PDL cells   .......................................................... 56 
Figure 16: 72-hour mean pg/ml concentrations PDL cells ............................................................ 58 
Figure 17: Average pg/ml of IL-6 from 24-72 hours  .................................................................... 59 
Figure 18: Averages of groups in pg/ml of IL-6 over 24-72 hours  ............................................... 60 
 
 
 
 
viii 
 
 
 
LIST OF TABLES 
Table 1: List of cytokine/growth factors present in PRF  .............................................................. 10 
Table 2: Histological grading scale  ............................................................................................... 28 
Table 3: Patient characteristics at baseline  ................................................................................... 39 
Table 4: Pre-treatment tooth characteristics Figure 1: PRF Layers After Centrifugation  ............ 39 
Table 5: Post-treatment tooth characteristics  ................................................................................ 40 
Table 6: Out of mouth time per treatment group  .......................................................................... 40 
Table 7: Changes in EPT over time  .............................................................................................. 41 
Table 8: Multivariate model of changes in EPT over time  ........................................................... 42 
Table 9: Changes in thermal over time  ......................................................................................... 43 
Table 10: Multivariate model of changes in Thermal over time (data on the logit scale) ............. 44 
Table 11: Changes in percussion over time  .................................................................................. 45 
Table 12: Multivariate model of changes in percussion over time (data on the logit scale) .......... 46 
Table 13: Post-treatment tooth characteristics – histology (at the tooth level) .............................. 47 
Table 14: Multivariate model of evidence of vitality  ................................................................... 48 
Table 15: Evidence of vitality based on pre-diagnostic tests  ........................................................ 53 
Table 16: Evidence of vitality based on post-diagnostic tests  ...................................................... 53 
Table 17: ELISA data in pg/ml of IL-6.......................................................................................... 54 
Table 18: 24-hour culture group IL-6 production comparison  ..................................................... 54 
Table 19: 48-hour culture group IL-6 production comparison  ..................................................... 56 
Table 20: 72-hour culture group IL-6 production comparison  ..................................................... 57 
Table 21: Average 24-72 hour culture group IL-6 production comparison ................................... 59 
 
  
ix 
 
 LIST OF ABBREVIATIONS 
ANOVA  one-way analysis of variance 
EGF   epidermal growth factor 
ELISA   enzyme-linked immunosorbent assay 
EPT   electric pulp test 
FBS   fetal bovine serum 
FGF   fibroblast growth factor 
DMEM   Dulbecco’s modified eagle’s culture medium 
GLMM   generalized linear mixed model 
H&E   hematoxylin and eosin 
IL   interleukin  
IGF   insulin-like growth factor 
L-PRF    leukocyte and platelet-rich fibrin 
L-PRP   leukocyte and platelet-rich plasma 
LPS   lipopolysaccharide  
Ml   milliliter  
MMP   matrix metalloproteinase 
MTA   mineral trioxide aggregate 
OR   odds ratio 
PDL   periodontal ligament 
PDGF   platelet-derived growth factor 
PG   picograms 
PRF   platelet-rich fibrin 
x 
 
P-PRF   pure platelet-rich fibrin 
PRP   platelet-rich plasma 
P-PRP    pure platelet-rich plasma 
TGF   transforming growth factor 
TIMP   tissue inhibitor of metalloproteinases 
TNF   tumor necrosis factor  
TSP   thrombospondin 
UNMC COD  University of Nebraska Medical Center College of Dentistry  
VEGF   vascular endothelial growth factor 
 
 
1 
 
CHAPTER 1: INTRODUCTION  
Pulpal necrosis after reimplantation, in either avulsion or autotransplantation, is a clinical 
complication. If the pulp tissue is not regenerated, or if endodontic therapy is not performed, the 
pulp space can become infected (Tronstad 1988). It has been suggested that treatment strategies 
should attempt to limit peri-radicular inflammation therefore promoting favorable cemental 
healing, pulpal revascularizaion, and limiting unfavorable osseous replacement (Trope, 2002).  
To achieve regeneration of the dental pulp, three main elements are required. The first 
element is a source of cells that are capable of differentiating into the desired tissue (Hargreaves 
et al., 2013). Stem cells have been reported in both the dental pulp and the apical papilla 
(Nakashima & Akamine, 2005; Huang et al., 2008). The second element is the presence of 
growth factors and other tissue-inducing mediators. The third element is a scaffold, or a three 
dimensional tissue structure that regulates the release of the growth factors (Hargreaves et al., 
2013). These characteristics drive the investigation for an ideal medium capable of promoting 
endodontic revascularization and eventually the potential for regeneration of avulsed or 
autotransplanted mature teeth. In a review article on pulpal regeneration of permanent teeth, 
Haregreaves et al. (2008) suggested that platelet concentrates may be a promising material for 
endodontics as they possess the characteristics required to achieve regeneration.  
Platelet rich fibrin (PRF) is a second generation platelet concentrate that allows the 
clinician to obtain fibrin membranes enriched with platelets and growth factors from an 
anticoagulant-free blood harvest and without the addition of artificial biochemical modification 
(Dohan et al., 2006). PRF has demonstrated clinical relevance through its ability to stimulate cell 
proliferation of osteoblasts, gingival fibroblasts, and PDL cells. In addition, the PRF membrane 
includes VEGF, a potent stimulator of angiogenesis. These properties make it a favorable product 
for surgical procedures where revascularization is desirable (Tsai et al., 2009).  
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To date, no human studies have been performed evaluating the effectiveness of PRF on 
pulpal revascularization after reimplantation. Additionally, only histological evidence of the 
benefits of PRF has been demonstrated in animal models. Peters (2014) discussed the need for a 
broader spectrum of inclusion for cases attempting regeneration. Currently it is mostly limited to 
immature teeth with larger apical foramina. The article emphasizes the need to expand the 
evaluation of endodontic regeneration potential in mature teeth. Additionally, a further 
understanding of PRF’s role in modulating inflammation is needed. A human trial evaluating PRF 
as an adjunct to endodontic regeneration could offer more insight on its potential for inducing 
pulpal regeneration of necrotic teeth. If PRF is capable of promoting regeneration in mature teeth, 
the potential benefits include limiting the need for endodontic therapy following tooth avulsion, 
potential for mature tooth transplantation in situations of congenitally missing teeth, and 
utilization of PRF in endodontic regeneration therapy of mature necrotic teeth.  
The purpose of this study is to evaluate the inflammatory response of PRF in vitro, and 
analyze clinically and histologically the effectiveness of PRF on pulpal regeneration after 
reimplantation. The central hypothesis of this study is that PRF has anti-inflammatory properties 
that can aid in pulpal regeneration during reimplantation procedures or in cases of avulsion. The 
second hypothesis is that introducing PRF into the apical foramen during autotransplanation will 
enhance the regeneration of the pulpal tissue and improve clinical vitality results. Both 
hypotheses will be tested through the following aims: 
1) Evaluate the PDL cell inflammatory response to LPS through measurement of IL-6 
cytokine in the presence of PRF 
2) Determine if PRF effects the clinical vitality of an extracted and reimplanted tooth by 
measuring responses to percussion, cold, and electric pulp test (EPT) 
3) Evaluate histologically the inflammatory infiltrate and presence or absence of 
vascularity in the pulp chambers and canals of the teeth treated with or without PRF 
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CHAPTER 2: LITERATURE REVIEW 
Regenerative endodontics: mature tooth avulsion 
Dental trauma occurs frequently in children with an estimated 4-59% prevalence of 
dental trauma around the world. This oral trauma frequently leads to pulpal necrosis (Gelndor & 
Andreasen, 2007). Approximately 92% of avulsion cases of traumatized permanent teeth leads to 
pulpal necrosis (Borum & Andreasen, 2001). This necrotic tissue is at high risk for bacterial 
contamination. If the pulp tissue does not revascularize or if endodontic therapy is not performed, 
the pulp space can become infected (Tronstad, 1988). It has been suggested that treatment 
strategies should attempt to limit peri-radicular inflammation, therefore promoting favorable 
cemental healing, pulpal revascularizaion, and limiting unfavorable osseous replacement (Trope, 
2002). Whole pulp regeneration is considered the reconstitution of viable tissue in a space that 
was previously avascular (Peters, 2014).  
Regenerative endodontics is the formation and delivery of tissues to replace pulp that has 
been traumatized or is diseased or absent (Murray et al., 2007). Clinical endodontic regenerative 
treatment is still considered a challenge even for immature teeth, and for mature teeth is an area 
of endodontics where more research is needed. Regenerative endodontics has been mostly 
focused on immature teeth as they have a greater chance for pulpal regeneration; however, some 
case studies suggest potential to expand the practice to mature necrotic teeth. Payani & Kim 
(2013) published two case reports where a modified regenerative endodontic procedure was 
utilized in place of conventional endodontics for traumatized mature teeth. They observed a 
regression of the clinical symptoms and resolution of the apical radiolucency in both cases.   
To achieve regeneration of the dental pulp, three main elements are required. The first 
element is a source of cells that are capable of differentiating into the desired tissue (Hargreaves 
et al., 2013). Stem cells have been reported in both the dental pulp and the apical papilla 
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(Nakashima & Akamine, 2005; Huang et al., 2008). The second element is the presence of 
growth factors and other tissue-inducing mediators. The third element is a scaffold, or a three- 
dimensional tissue structure that regulates the release of the growth factors (Haregreaves et al., 
2013). These characteristics drive the investigation for an ideal medium capable of promoting 
endodontic revascularization and eventually the potential for regeneration of avulsed or 
autotransplanted mature teeth. In a review article on pulpal regeneration of permanent teeth, 
Haregreaves et al. (2008) suggests that platelet concentrates may be a promising material for 
endodontics as they possess the characteristics required to achieve regeneration.  
Platelets and platelet concentrates: A history 
Platelets, also referred to as thrombocytes, are a component of mammalian whole blood. 
The function of platelets is primarily hemostasis through aggregation at an injured portion of a 
blood vessel wall. Platelets are derived from bone marrow megakaryocytes, are discoidal 
anucleate cytoplasmic fragments, and are on average 2-3 μm in diameter. They are not actually 
true cells, in actuality they are circulating cell fragments. A normal platelet count for an adult 
human is 1.5-4 thousand per µL in peripheral blood, and the average lifespan of a platelet is 
approximately 8-10 days (Dohan et al., 2006). During tissue repair, platelets that have been 
activated will release two different types of granules. The dense granules have serotonin, 
adenosine triphosphotase, adenosine diphosphotase, and calcium (De Pascale et al., 2015). 
Platelets also contain α-granules, a few mitochondria, and two prominent membrane structures. 
The α-granules are spherical or oval structures with diameters ranging from 200-500 nm, each 
enclosed within a membrane. These α-granules activate signaling proteins, which ultimately 
result in gene expression for cellular proliferation, matrix formation, collagen synthesis, and 
osteoid production (Gasling et al., 2009). The growth factors present in these α-granules exhibit 
chemotactic and mitogenic properties which assist in promoting cell proliferation and modulating 
cell functions that promote tissue healing and regeneration (Anitua et al., 2007) 
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Platelet concentrations were first utilized in transfusion medicine for the prevention of 
hemorrhage induced by severe thrombocytopenia (Dohan et al., 2008). The benefit of these 
concentrates to assist in healing and stimulation of wound repair was initially explored through 
the surgical application of fibrin glues. These glues consisted of concentrated fibrinogen (Matras 
et al., 1970). The regenerative use for platelets was first described by Ross et al. in 1974. In this 
study, Ross et al. (1974) demonstrated that platelet-poor plasma is much less effective than blood 
serum in the proliferation of cultured monkey arterial smooth muscle. Addition of platelets to the 
platelet-poor plasma increased activity; therefore, indicating a potential role of the platelet in 
wound healing in vivo. Choukroun was the first to develop platelet rich fibrin, also termed 
leukocyte and platelet-rich fibrin (L-PRF). Most platelet concentrate protocols lead to a low-
density fibrin gel, which has benefits in surgical application due to pliability and ease of use; 
however, it does not possess a true fibrin matrix. For the fibrin to be considered a biomaterial and 
have potential healing effects, it must be a high density fibrin network.  
Depending on the methods after collection of the whole blood, the result can lead to four 
different platelet concentrate products. The concentrates that can be produced are pure platelet-
rich plasma (P-PRP), leukocyte-rich platelet rich plasma (L-PRP), pure platelet-rich fibrin (P-
PRF), and L-PRF (Dohan et al., 2009). The fabrication of P-PRP leads to a low platelet collection 
as it attempts to avoid the collection of leukocytes which are usually found along with platelets in 
the intermediate layer. The P-PRP procedure lacks consistency and the release of cytokines 
occurs in a shorter duration than with PRF. With L-PRP the leukocytes which were previously 
undesirable with fabrication of P-PRP are now included. The final product of L-PRP is rich in 
leukocytes; however, it disintegrates quickly. Additionally, the machinery and biologics required 
to fabricate L-PRP make it an expensive and time-consuming process (Dohan et al., 2009). P-
PRF is leukocyte poor and has to be mixed with an anticoagulant and separation gel.  
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This process is both difficult to execute and the equipment needed is expensive. Finally, L-PRF 
(or Choukroun’s PRF) is a simple and free technique that was developed to minimize blood 
handling and remove the need for additives.  
Characteristics of L-PRF: 
L-PRF, or from here simply referred to as PRF, derives from a natural and progressive 
polymerization occurring during the centrifugation of the blood without any additives 
(Choukroun et al., 2001; Dohan & Choukroun, 2006). Without anticoagulants, fibrin 
polymerization begins immediately after collection. This slow and natural polymerization process 
of the fibrin results in a 3-dimensional and homogenous matrix during the centrifugation process 
(Dohan et al, 2006). This polymerization and centrifugation leads to a strong, yet flexible and 
elastic fibrin matrix with platelet cytokine and glycan chains embedded within the fibrin meshes 
(Khiste & Tari, 2013). After centrifugation is complete, three layers are formed: the red blood cell 
or corpuscle layer, the acellular plasma layer on top and the fibrin clot in the middle. The strong 
fibrin matrix has a three-dimensional architecture where most of the platelets and leukocytes are 
concentrated (Dohan et al., 2009). Fabrication of the PRF involves drawing whole blood into two 
10 ml glass tubes and immediately centrifuging at 2700-3000 rpm for 10-12 minutes. This 
process results in the three layers previously discussed. As the blood begins to coagulate during 
the collection process, rapid handling is essential (Gupta et al., 2011). The diagram below 
demonstrates the three different layers that are obtained after centrifugation. 
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Figure 1: PRF Layers After Centrifugation 
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There are numerous benefits to not discarding the leukocytes, as is done with P-PRF 
(Dohan et al. 2009). Firstly, the presence of leukocytes promotes the in vivo recruitment of new 
leukocytes aiding in inflammation and tissue repair (Zumstein et al., 2012).  Regarding the 
obvious anti-infectious role, leukocytes and monocytes present in the PRF (or recruited from in-
vivo activation) contain high levels of myeloperoxidase, which is toxic to bacteria (Everts et al., 
2006). The combination of inductive and antimicrobial properties has made many advocate its use 
in non-healing wounds. Platelet concentrate antimicrobial activity against Staphylococcus aureus 
was shown to be equivalent to gentamicin and oxacillin and additionally was shown to have 
significant effects in reducing the growth of Escherichia coli (Bielecki et al., 2007). The 
synergistic antibacterial effect of both leukocytes and platelets yield supreme potential for 
antimicrobial activity. Platelet α-granules contain not only growth factors and antimicrobial 
peptides, but also catecholamines, serotonin, osteonectin, von Willebrand factor, proaccelerin, 
and other substances. (Anitua et al., 2005; Bielecki et al., 2006; Slater et al., 1995). These are 
released in high concentrations after platelet aggregation and may have antibacterial effects 
(Bielecki et al., 2007). Additional benefits to preserving leukocytes is that they produce large 
amounts of VEGF, which fosters healing and stimulates angiogenesis (Dohan et al., 2009; 
Nielsen et al., 2001; Werther et al., 2002). As a decrease in vascularity is seen with age, having a 
higher leukocyte count assists in higher levels of vascular endothelial growth factor (VEGF), 
which assists in the induction of new vessel growth (Zumstein et al., 2012). This angiogenesis 
potential is further promoted by the fibrin structure as fibrin induces healing after 4 days, in 
addition to cellular interactions and angiogenesis by replacement of the fibrin by capillaries 
(Butler et al., 2008; Laurens & Koolwijk, 2006).   
PRF has been shown to be efficient in cell migration, proliferation, and cicatrisation 
(Bensaid et al., 2003; Laurens & Koolwijk, 2006). Using platelet concentrations in wound healing 
for either hard or soft tissue is mediated by a wide range of signaling proteins and intra and 
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extracellular events (Gasling et al., 2009). Activation and degranulation of the α-granules releases 
cytokines interleukin (IL)-1β, IL-6, TNF-α and growth factors TGF β1, PDGF, VEGF, EGF 
which initiate healing through stimulating cell migration and proliferation (Dohan et al., 2006). 
Dohan et al. (2006) suggests that through these cell mediators, PRF may act as an immune 
regulator and decrease some of the harmful effects of inflammation of surrounding tissues during 
wound healing. Below is a table adapted from information in Hotwani & Sharma (2014) 
describing the growth factors and cytokines identified in PRF and their role in inflammation and 
wound healing.  
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Table 1: List of cytokine/growth factors present in PRF 
IL-1 Stimulates T-helper cells, inflammatory 
mediator 
IL-6 B cell differentiation, T cell activator, 
antibody secretion stimulation, 
inflammatory and remodeling mediator 
IL-4 Proliferation and differentiation of 
activated B cells, moderates inflammation, 
increases fibroblast synthesis of fibrillary 
collagen 
TNF-α Monocyte activator, stimulate fibroblast 
remodeling, increase phagocytosis and 
neutrophil toxicity, modulates IL-1 and IL-
6 expression 
VEGF Initiates angiogenesis 
TGF β1 Significant synthesis of collagen and 
fibronectin 
PDGF Regulates migration, proliferation and 
survival of mesenchymal cell lineages, 
cicatrisation 
IGFs 1 and 2 Mediator in apoptosis, chemotactic effects 
towards human osteoblasts 
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These growth factors are released from platelets when activated by a stimulus or 
aggregated by activators (Kaplan et al. 1978). A brief review of the cytokines and growth factors 
present in a PRF membrane will demonstrate its influence in wound healing. IL-1, an 
inflammatory mediator, activates osteoclasts and inhibits bone formation. TNF-α stimulates 
fibroblasts and monocytes and modulates IL-1 and IL-6 (Gupta et al., 2011). IL-4 promotes 
healing by modulating inflammation, increasing collagen synthesis and inhibiting MMPs. 
Through the presence of IL-4, it is suggested that PRF prevents the production of IL-1β, TNF-α, 
and prostaglandins when presented with bacterial endotoxin. TGF-β1 is a strong fibrosis agent 
inducing collagen and fibronectin synthesis. PDGF assists in the production of cicatricial tissue as 
wound healing progresses. IGFs instigate osteoblast activation and mediate apoptosis (Gupta et 
al., 2011). VEGF is a powerful vascular endothelial growth factor, which initiates angiogenesis 
and is capable of directing and redefining the network growth (Dohan et al., 2006). In fact, the 
release of pro inflammatory cytokines IL-1β, IL-6 and TNF-α along with anti-inflammatory 
cytokine IL-4 from PRF additionally accelerate angiogenesis (Schmid et al., 1997).  
Characteristics of PRF: An emphasis on IL-6 
The presence of IL-6 in PRF, and PRF’s ability to induce IL-6 release from surrounding 
tissue, is of particular interest. IL-6 is a potent stimulator of inflammation, and therefore a good 
marker for determining a material’s pro- and anti-inflammatory potential. IL-6 is a pleiotropic 
cytokine that provokes both cellular and physiological responses on a broad spectrum. These 
responses include, but are not limited to: inflammation, immune response, hematopoiesis, gene 
activation, and proliferation, survival, and differentiation (Hirano et al., 1990).  IL-6, along with 
other pro-inflammatory cytokines like IL-1β, TNF- α, and TGF-β, are produced by many cell 
types in the body (Gabay, 2006). IL-6 is produced at the site of inflammation and is a key player 
in the acute phase response as well as the transition into chronic inflammation.  
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IL-6 expression can be stimulated by IL-1, bacterial endotoxin, TNF-α, and PDGF. IL-6 acts as a 
major amplifier for immune cells and leads to a combined response of destruction, inflammation, 
and remodeling (Dohan, 2006).  
While IL-6 is produced by a variety of human cells, the IL-6 receptor (IL-6R) is 
expressed on few cells, namely hepatocytes, monocytes, B cells, a subset of T cells, and 
neutrophils (Barnes et al., 2011). IL-6 principally induces responses from fibroblasts, endothelial 
cells, and monocytes (Dohan 2006).  At inflammatory sites the most important sources of these 
pro-inflammatory cytokines are monocytes and macrophages. IL-6 has dual roles as it can act as a 
defense mechanism by aiding in acute inflammation, but in chronic inflammation it is considered 
pro-inflammatory. (Gabay, 2006).  IL-6 is important for the transition from acute inflammation 
into a chronic state by primarily changing the nature of the leukocyte infiltrate. This is 
accomplished by altering the neutrophil population as well as by inducing the differentiation of 
monocytes to macrophages (Mitani et al., 2000). By investigating the responses of these cells to 
IL-6, it becomes apparent that IL-6 is a major player in both acute and chronic inflammation.  
Acute inflammation is a limited physiological response that requires resolution in a short 
period of time and in a localized area. If this is improbable, chronic inflammation will follow. 
During this phase, IL-6 can have a protective effect by suppressing pro inflammatory cytokine 
levels without compromising levels of anti-inflammatory cytokines (Xing et al., 1998; Kaplanski 
et al., 2003). It additionally stimulates IL-1 receptor antagonist, an anti-inflammatory mediator. 
Therefore, offering some prolongation of the acute phase (Gabay et al., 1997). Acute 
inflammation is represented by a leukocyte infiltrate that is primarily neutrophilic (Gabay, 2006). 
Endothelial cells (the epithelial lining of blood vessels) and fibroblasts (a connective tissue cell) 
do not express IL-6R, but rather, interact with IL-6 via trans-signaling (utilizing a soluble 
receptor) (Romano et al., 1997). IL-6 plays a role in angiogenesis through stimulation of 
fibroblasts. As a profibrogenic cytokine, it has been shown to increase fibroblast proliferation, 
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collagen production, tissue inhibitor of metalloproteinases-1 (TIMP-1), and regulate the 
expression of VEGF (Mihara et al., 1995). This can assist in modulating the amount of tissue 
destruction occurring during inflammation, as well as encourage healing and vessel proliferation. 
Activation of endothelial cells via trans-signaling leads to expression of various adhesion 
molecules, including intercellular adhesion molecule 1, which promote leukocyte migration to the 
site, and the release of chemokines like IL-8, which induces neutrophil migration. Additionally, 
IL-6 stimulates endothelial cells and fibroblasts to produce more IL-6, creating a positive 
autocrine feedback system. In this manner, IL-6 assists early on in promoting leukocyte, namely 
neutrophil, chemotaxis to the area of infection; however, as the process matures, IL-6 encourages 
a shift to chronic inflammation (Barnes et al., 2011).  
Monocytes are white blood cells that can differentiate into macrophages or dendritic cells 
depending on cytokine stimulation (Mitani et al., 2000). Once inflammation has progressed to a 
chronic state, additional tissue damage begins occurring. After 24 to 48 hours the transition to 
chronic inflammation histologically reveals primarily monocytes and lymphocytes. Since IL-6 
encourages end-stage B lymphocyte differentiation (into plasma cells), immunoglobulin 
secretion, and T lymphocyte proliferation and differentiation, it is therefore a key modulator in 
the progression to the chronic inflammatory state (Gabay, 2006). IL-6 has been demonstrated to 
favor the proliferation of Th1 cells (T helper cell that act primarily against bacteria and protozoa) 
and to contribute to IL-2 expression furthering chronic inflammation (Jones et al., 2005). By 
promoting the maturation of B lymphocytes into plasma cells, IL-6 assists in inducing the 
production of antibodies at the site of infection. This enhances lymphocyte migration to the area 
of inflammation, propagates the chronic inflammatory state, and ultimately leads to an increase in 
tissue destruction (Hirano, 1992). The length of this phase can also be influenced by IL-6 as it 
dictates apoptotic clearance of leukocytes like neutrophils, monocytes, and lymphocytes (Jones et 
al., 2005). IL-6 has been reported to induce neutrophil apoptosis while simultaneously rescuing 
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T-cells from apoptosis, therefore propagating the shift from acute to chronic stages of 
inflammation (Barnes et al., 2011). In this manner, IL-6 appears to be capable of dramatically 
influence the nature of the immune response through dictation of recruitment, activation, and 
apoptotic clearance of specific leukocyte subpopulations (Jones et al., 2005).  
PRF application: Surgical benefits 
During wound healing, endothelial cells, leukocytes, and platelets are important players 
in the formation of the initial platelet plug during hemostasis, and later in tissue regeneration (De 
Pascale et al., 2015). Historically, the first clinical application of a platelet-derived preparation 
was with collagen embedded with platelet proteins placed in chronic leg ulcers. This product 
stimulated vascularized connective tissue in the chronic wounds (Krupski et al., 1991; Ganio et 
al., 1993). Once fabricated, PRF can be compressed between two damp gauze yielding a strong 
membrane applicable in many surgical situations. It is thought that platelets are immediately 
activated upon application and that growth factors are massively released during the first hours 
after placement on the surgical site (Dohan et al., 2009). Unlike PRP, PRF does not dissolve 
within hours after application, but instead begins the slow remodeling process and disintegration 
of the fibrin complex. This slow resorption allows for a continuous release of the cytokines 
embedded within this fibrin matrix.  Dohan et al. (2008) demonstrated that over the course of 1 
week, PRF membrane sustains a very significant slow release of key growth factors. This 
suggests that the membrane stimulates its environment for a significant amount of time during its 
remodeling phase.  
PRF has become a valuable adjunct to surgery in both the medical and dental fields 
through its combination of high efficiency platelet and leukocyte collection in a stable matrix, 
along with activation of growth factors and preservation of tissue repairing cytokines. Many 
studies advocate its use in rotator cuff and other orthopedic procedures for these very same 
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characteristics (Bielecki et al., 2007; Zumstein et al., 2012). In oral surgery, it has many 
recommended applications including: as a membrane, inclusion in implant placement, post 
enucleation of large periapical lesions, surgical removal of impacted third molars and impacted 
canines, and pre-prosthetic surgeries to enhance bone density and soft tissue healing (Saluja et al., 
2011; Sunitha & Munirathnam, 2008). Kawamura and Urist (1988) demonstrated that PRF may 
act as a supportive matrix for bone morphogenetic protein as well. Chang et al. (2010) showed 
that PRF can be utilized to modulate the expression of osteoprotegerin and osteoblast 
proliferation. PRF has become a popular adjunct during bone grafting and other forms of 
reconstructive surgery.  
PRF application: Use in regenerative endodontics 
PRF was determined to be an ideal medium for revascularization of pulpal tissue due to 
the presence of major cytokines entrapped within the fibrin mesh. According to Dohan et al. 
2006, an ELISA test was performed on PRF samples and the concentrations of five different 
cytokines was compared within the PRF clot and the blood serum. It is suggested that the fibrin 
mesh entraps these cytokines and as the fibrin degrades over time, it allows for slow release of 
these cytokines into the surrounding tissues. In a study by He et al. (2009) PRP and PRF in 
medium were evaluated to determine the release of TGF-β1 and PDGF over the course of 28 
days. PRP was shown to release growth factors more rapidly but then concentrations declined. 
PRF demonstrated a gradual release in growth factors and their activity was kept up for a longer 
period of time compared to PRP. PRF exhibited a controlled and long-term release of growth 
factors where the highest amount was measured at day fourteen. In comparison, PRP had a more 
uncontrolled and short term release of the measured growth factors with its highest concentration 
on the first day. Due to this slow release, the investigators observed stimulation of rat calvaria 
osteoblasts from exudate of PRF but not PRP after day 14 (He et al., 2009). Additionally, Schar et 
al. (2015) observed that in comparison to PRP, PRF in medium had a higher release of TGF-β1, a 
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long-term release of growth factors, and was a stronger inducer of mesenchymal cell migration. 
PRF also had marginally higher release of VEGF and IGF-1.  
The intrinsic incorporation of cytokines within the fibrin mesh allows for their 
progressive release over time (approximately 7-11 days), as the network of fibrin disintegrates 
around it (Huang 2010). Due to the solid consistency of the fibrin network, PRF membranes are 
slowly destroyed by a remodeling process, similar to a natural blood clot (Clark, 2001). The 
platelet cytokines that are gradually released as the matrix is resorbed leads to a sustained process 
of healing (Huang, 2010). The integration of this fibrin network into a site for regeneration 
facilitates cellular migration, particularly for endothelial cells necessary for neo-angiogenesis and 
vascularization (Dohan, 2006). Other benefits include the presence of leukocytes and cytokines in 
the fibrin network which can play a significant role in the self-regulation of inflammatory and 
infectious processes in areas of regeneration (Simonpieri, 2009). Additionally, the PRF 
membrane can offer a structural support and function similar to a fibrin bandage over a wound 
and accelerate the healing of the wound edges (Gassling, 2009). 
Regenerative endodontics is based on the idea that despite a tooth being classified as 
necrotic, some pulpal tissue can survive in the apical region and if conditions are favorable, can 
be utilized to proliferate pulpal tissue and accomplish regeneration (Trope, 2010). In 
autotransplantation, replantation, and regenerative endodontic therapy, revascularization of the 
pulp chamber by ingrowth from the surrounding periapical tissues, passing through the apical 
foramen determines the success of these procedures (Laureys et al. 2013). While there is no 
standardized method for revitalizing a necrotic tooth, endodontic literature has investigated the 
benefits of PRF as an adjunct to apexification and pulpal revascularization. The sustained release 
of key growth factors, the trimolecular fibrin scaffold that allows for flexibility, and its ability to 
support cytokine enmeshment and cellular migration, are all reasons why PRF has recently gained 
attention as an ideal pulp capping material. Shivashankar et al. (2012), Khetarpal (2013), and 
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Rudagi & Rudagi (2012) published case reports on PRF in combination with mineral trioxide 
aggregate (MTA) in managing cases with open apexes and found accelerated periapical healing 
and apical bone formation. In a case report by Shivashankar et al. (2012), treatment of a 9-year-
old boy with a fractured immature maxillary central incisor involved irrigation of the accessed 
canal with 5.25% sodium hypochlorite and .2% chlorhexidine followed by medicating the 
traumatized tooth with triple antibiotic paste for 21 days. After this time period, the paste was 
removed, whole blood was drawn from the boy’s arm and used to fabricate PRF, via Choukroun’s 
method. The PRF was packed into the canal to the level of the CEJ and MTA was placed over the 
top of it. A year later the tooth responded positively to vitality testing and demonstrated 
radiographic evidence of continued root lengthening and apex closure.   
Shivashankar et al. (2012) cited in vitro studies with PRF and canine and human dental 
pulp cells as to why PRF is a choice material for pulpal revascularization. In vitro analysis with 
canine pulp cells has corroborated PRF’s ability to promote chemotaxis and proliferation of the 
pulp cells and its ability to contribute to pulpal repair (Yang et al., 2013). When PRF was 
combined with human dental pulp cells derived from extracted third molars, it did not interfere 
with vitality and stimulated proliferation and differentiation. Additionally, it upregulated the 
expression of osteoprotegerin and alkaline phosphatase suggesting it may be beneficial in the 
formation of reparative dentin (Huang et al., 2010). Expression of these cytokines is usually 
regarded as a marker for odontoblastic differentiation. After regression of initial inflammation 
associated with an insult, the remaining dental pulp cells in the apical region differentiate into 
odontoblast like cells under the influence of Hertwigs Epithelial Root Sheath (Huang et al., 
2010). In the case study by Shivashankar et al. (2012), since no intracanal bleeding was 
instigated, regenerated vital tissue can be attributed to the presence of the PRF.  
Additionally, PRF has been shown to be compatible with PDL cells. PDL cells are 
fibroblast like cells that are characterized by collagen production and some osteoblastic features. 
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PDL cells produce numerous cytokines and chemokines in response to promoters of inflammation 
(Jönsson et al., 2011). Zhao et al. (2013) investigated PDL cells in combination with PRF to 
enhance periodontal healing in an avulsed tooth that has been reimplanted. This study 
demonstrated that PDL cells and PRF are compatible and that PRF and PDL cells may enhance 
the healing of avulsed teeth.  
PRF application: Use in avulsion and tooth transplantation 
The clinical utility of PRF and revascularization has also been demonstrated in several 
case studies of avulsion (Johns et al., 2013; Keswani et al., 2013; Mishra et al., 2013). These 
reports utilized a general protocol of minimally instrumenting the avulsed tooth. Johns et al. 
(2013) performed a 3 mm resection of the root apex followed by minimal instrumentation of the 
canal. Blood is then drawn from the patient and PRF is prepared via Choukroun’s method. The 
PRF is then placed on the root surface and condensed into the canal. The tooth was then 
reimplanted, splinted, and the patient followed for up to 24 months. The tooth tested vital to 
thermal and percussion testing and radiographically did not show signs of replacement resorption 
or inflammation.  
The reasoning for the enlargement of the apical foramen was discussed by Andreasen et 
al. (1990) in an autotransplantation study involving 370 premolars. It was determined that an 
apical foramen of at least 1 mm is required for adequate revascularization of autotransplanted 
teeth. It was demonstrated that an apical foramen smaller than 1 mm resulted in unpredictable 
revascularization of the pulp tissue and only 15% of mature teeth with closed apices had vital 
pulp after transplantation. While the benefits of enlargement of the apical foramen has been 
demonstrated, there does not seem to be any precise minimal apical foramen diameter. In a beagle 
study, Laureys et al. (2013) saw revascularization with an apical foramen of .32 mm.  In a series 
of dog studies, Skogland’s group showed that if the apical foramen is enlarged via an 
19 
 
apicoectomy, mature teeth can be revascularized with a high success rate (Skogland et al. 1981; 
Skogland et al. 1978; Skogland and Tronstad 1981). In their studies, control teeth that were 
transplanted without apicoectomies did not demonstrate revascularization when evaluated with a 
microangiographic technique. In a study by Laureys et al. (2010), 29 beagle teeth with root tip 
resections were reimplanted and followed for 90 days. The investigators observed that 80% of 
teeth with pulp tissue left in the canal showed 1/3-complete fill with viable pulp tissue, whereas 
the group where the pulp tissue was removed prior to reimplantation demonstrated a 79% loss of 
viability. The conclusion is that the pulp tissue in the canal assists in stimulating revascularization 
and tissue ingrowth through the apical foramen.  
Additionally, PRF has been shown to reduce inflammation; an exaggerated inflammatory 
process sometimes causes deleterious ankylosis in traumatized teeth. Animal models evaluated 
PRF granules combined with human PDL stem cells placed on the root surface of freshly 
extracted canine teeth. The teeth were then reimplanted and evaluated histologically after a 
healing phase. A regeneration of the PDL-like tissue and reduction in ankylosis and inflammation 
were noted in animals with the PRF granules (Zhao et al., 2013). While these studies suggest that 
PRF may be a valuable additive in attempting pulpal revascularization after traumatic avulsion of 
the adult dentition, more information is needed on its capabilities and limitations. Further study of 
cytokine and growth factor components of PRF are needed to determine the proinflammatory and 
anti-inflammatory capabilities of PRF. Additionally, a controlled clinical trial in humans with the 
reimplantation model utilized by Skogland and Laureys would aid in understanding PRF’s role in 
pulpal regeneration in auotransplantation or avulsion cases.   
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CHAPTER 3: MATERIALS AND METHODS 
Both the in vitro and in vivo portions of the study were approved by the Institutional 
Review Board for Human Studies of the University of Nebraska Medical Center (# 443-14-FB) 
Clinical Trial: 
Investigator Calibration: 
 Investigator EE underwent a calibration exercise prior to the start of the study. EE 
collected 6 extracted healthy teeth with single roots from the College of Dentistry’s 
Undergraduate Oral Surgery Department. EE performed an apicoectomy, enlarged the apical 
foramen to at least 1 mm (measured with a dental probe), and accessed the pulp chamber 
coronally to allow fixation of tissue in accordance to the study design. Teeth were then examined 
histologically to ensure that pulpal tissue could be properly fixed and stained. These teeth were 
used as baseline controls of ideal pulpal histology.  
Study Population and Design: 
This study was designed as a prospective randomized, controlled clinical trial. A total of 
18 patients were enrolled. Patients receiving treatment at the University of Nebraska Medical 
Center College of Dentistry (UNMC COD) that met the inclusion criteria were identified by 
investigator EE. The inclusion criteria included any adult (age 19 or older) with single rooted 
vital teeth previously treatment planned by UNMC COD prosthodontic faculty for extraction. 
These teeth were required to test positive to EPT but not necessarily to thermal. Exclusion criteria 
included: uncontrolled diabetics with a reported HBA1c level of 8 or above (taken within the past 
3 months), pregnancy, or currently anyone taking or having a history of taking oral or IV 
bisphosphonates. A detailed informed consent was obtained from all subjects and all subjects 
were given the opportunity to ask questions before signing the consent form.  
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Figure 2: Flow of Clinical Study Design   
Screening 
Stage II- At least 3 
months later retest for 
EPT, cold, percussion. 
(n= 69 teeth) 
Baseline results 
obtained: EPT, cold, 
percussion 
Stage I- Extract study teeth 
(2-3 test and 2-3 control), 
Apicoectomy, PRF (Pt. 
derived) placed on test. 
Splint. (n= 70 teeth) 
Informed consent 
obtained (n=18) 
Eligible patients 
identified and invited 
to participate (n= 18) 
Extract and 
prepare for 
histology 
Teeth removed from 
study due to patient 
discomfort (n=1) 
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Baseline Evaluations: 
Baseline evaluations were recorded to determine the initial vitality status of each tooth. 
Current radiographs were evaluated for signs of pathology associated with teeth utilized in the 
study. Vitality testing included a yes or no response to percussion, a yes or no response to thermal 
testing with Endo Ice (tetrafluoroethane; manufactured by Coltene), and a numerical value for 
EPT. If no response was elicited from EPT the value was placed at 80 and teeth were not included 
in the study. A hard tissue exam of selected teeth was also performed and caries recorded. 
Investigator EE performed all initial baseline evaluations and teeth were analyzed based off of 
how many tested positive or negative to each variable (percussion and cold) and then the EPT 
changes for all teeth were evaluated.   
PRF preparation: 
Venous blood (20 mL) was collected from each participant, the PRF was prepared 
according to a protocol described by Choukroun by investigator EE. The blood samples were 
transferred into two sterile 10-mL glass tubes without anticoagulation and the tubes immediately 
centrifuged at 3200 rpm for 12 min in Clay Adams Compact II centrifuge. Three layers were 
obtained: the platelet poor plasma, platelet rich fibrin clot, and the red corpuscle layer. The fibrin 
clot was easily separated from the red corpuscles at the bottom and divided into thirds with a 
sterile 15 blade.  
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Figure 3: Fabrication and preparation of PRF 
 
Figure Legend:  a) Fabrication of PRF demonstrating the three layers: the platelet poor 
plasma, the PRF clot, and the red blood cell layer b) Separation of fibrin clot from other 
layers c) Dividing the clot into thirds prior to intraoral placement. 
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Surgical Protocol and Root preparation: 
After obtaining informed consent, patients received 600 mg of clindamycin 
preoperatively. If needed, the teeth were initially debrided with a cavitron if visible plaque and 
calculus were present. Teeth were then atraumatically extracted by an oral surgeon (JB). After 
extraction, investigator EE performed an immediate root resection of 3 mm with a high-speed 
handpiece and a NS NTI super coarse diamond FG Axis (Dental Health Products). The resected 
root orifice was then enlarged with a ¼ round bur until the apical diameter was greater than 1 
mm. Total out of mouth time was recorded for each tooth.  
Application of PRF: 
Experimental and control teeth were determined at random via coin toss (performed by 
surgical assistant Betty Shestak) during surgery and investigator EE was blind to which teeth 
received the PRF intervention. In each patient, between 2-4 teeth were utilized. The PRF was 
condensed into the canal and permitted to extrude from the apex. The socket was rinsed with 
saline and teeth reimplanted using light pressure. The teeth were splinted to adjacent teeth with 
Ribbond (bondable reinforced ribbon, Ribbond, Inc.) and flowable composite for a minimum of 6 
weeks. Control teeth received all identical treatments with the exception of the PRF.  
25 
 
Figure 4: Apicoectomy, placement of PRF, and reimplantation with placement of splint 
 
 
 
 
 
Figure Legend:  a) Tooth preparing for apicoectomy b) Enlargement of apical foramen with ¼ 
round bur c) Placement of PRF into the apical foramen d) Tooth demonstrating PRF 
extruding from apex e) Teeth reimplanted and splinted.  
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Follow up: 
Patients were followed for a minimum of 3 months and a maximum of 11 months while 
their final prostheses were fabricated by UNMC COD dental students. At the end of this period, 
teeth underwent the exact same diagnostic testing performed pre-operatively (percussion, thermal, 
and EPT) by investigator EE. Teeth were atraumatically extracted and coronal pulpal access 
immediately obtained with a 6 mm round bur prior to placing in 10% buffered formalin. The 
patients were then followed for a minimum of 2 weeks to ensure healing and completion of their 
predesigned prosthetic treatment plan.  
Histological analysis: 
To obtain a baseline comparison of the histological features of a healthy pulp, 6 freshly 
extracted healthy teeth (from the same patient) were obtained from the UNMC College of 
Dentistry Predoctural Oral Surgery Clinic. These teeth were utilized to determine the normal 
characteristics of a healthy pulp not receiving any study interventions, and to serve as beneficial 
comparisons throughout the histological analysis of study teeth. 
 Histological evaluation was performed by investigators PG and EE (both blind to 
research intervention). After extraction, teeth were allowed to remain in formalin for 
approximately 1 week. Teeth were then transferred to 5% formic acid for 2-4 weeks depending on 
tooth size and time needed to decalcify. Completion of the decalcification process was 
determined by cutting the tooth in half at the midline with a new scalpel blade. Halves were then 
processed with a Tissue-Tek VIP processor with an overnight program. They were then 
embedded in paraffin and sectioned to 6-7 micron cuts with an American Optical Microtome. 
Sections were then stained with a routine Mayer’s hematoxylin and eosin (H&E) stain.  
Sections were then evaluated microscopically by PG and EE and descriptive histology 
recorded for each tooth. Infiltrate (acute, chronic, or mixed), severity (mild, moderate or severe), 
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presence or absence of fibroblast nuclei indicative of vital tissue (yes or no), and presence or 
absence of blood vessels (none, few, many observed) were recorded for each tooth. Table 2 
demonstrates the histological grading scale. If a determination could not be made from the slide, 
recuts were ordered until either: a determination of all four variables could be made, or the tooth 
was no longer able to be cut on the microtome. In the latter situation, the tooth was determined as 
inconclusive and was not utilized for statistical analysis. The histological examination was 
performed using a Nikon microscope and digital photomicrographs were obtained using a Nikon 
digital camera connected to a Zeiss Axiolab microscope. The system is designed to acquire high-
definition digital images at 10x, 20x, and 40x magnifications. 
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Table 2: Histological grading scale 
Degree Stage Vital Tissue 
Observed 
Blood Vessel 
Observation 
Mild Acute Yes None observed 
Moderate Mixed No Observed in some slices 
Severe Chronic  Observed in several 
slices 
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In vitro analysis of IL-6 and PRF: 
Study design: group designation and cell culture technique 
In the in vitro portion of the study, PDL cells were obtained from ScienCell (Carlsbad, 
CA) and grown in complete Dulbecco’s modified Eagle’s culture medium (DMEM) (Life 
Technologies, NY) supplemented with penicillin and 10% fetal bovine serum (FBS) at 37 °C in a 
humidified 5% CO2, atmosphere incubator.  
The following groups were analyzed:  Group A consisted of PDL cells and PRF. Group B 
consisted of PDL cells, PRF, and LPS. Group C acted as the positive control with PDL cells and 
LPS. Group D served as the negative control and consisted of only PDL cells in medium. To 
ensure that the cells would adhere to the actual PRF membrane and not just around it on the sides 
and floor of the wells, an initial histological evaluation of the membrane was performed. Whole 
blood was obtained from one of the healthy subjects and a PRF membrane was fabricated and 
then cultured with PDL cells in accordance with the protocol. After culturing for 24 h the 
membrane was removed and fixed in formalin, sectioned, and then stained. Histological 
evaluation revealed fibroblast attachment directly to the surface of the PRF membrane.  
  
30 
 
Figure 5: PRF membrane with PDL cell adherence  
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Study design: procedure 
Cells between the 4th and 8th passages were used. Whole blood was obtained from two 
different healthy subjects and PRF was fabricated according to protocol. PRF was divided into 
equal segments and placed in wells of groups A and B of a 24-well plate. A total of 1 x 106 PDL 
cells were plated in 96-well plates and cultured overnight in complete DMEM medium to allow 
adherence to the surface. 
After 24 h, the non-adherent cells were removed from the plates by aspiration and fresh 
complete culture medium was added. Cells were then stimulated with 25 ng/mL of LPS (Sigma) 
and incubated for 24, 48, and 72 h in 5% CO2 at 37°C and throughout the experiment an equal 
volume of fresh medium was added back to each well after collection. All collected culture 
supernatants were stored at –80°C before ELISA analysis. 
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Figure 6: PRF membranes in culture medium 
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Cytokine expression analysis: 
Supernatants were analyzed for IL-6 using standard ELISA techniques. ELISA kits 
utilized the quantitative sandwich technique. ELISA kits were purchased from eBioscience 
(Human IL-6 ELISA Ready-SET-Go! Kit, eBioscience, San Diego, CA, USA). All assay 
procedures were completed by one individual (EE). The ELISA tests were performed according 
to the manufacturer’s instructions and protocol. Supernatants were allowed to thaw at room 
temperature.  
100 µL of the standard or supernatant sample was pipetted into each well. Wells were 
pre-coated with Anti-Human IL-6 antibody. Samples and standards were then covered with a 
plate sealer and allowed to incubate overnight at 4 °C. All wells were then aspirated and washed a 
total of 5 times with wash buffer (1x PBS, 0.05% Tween-20). Following the wash, 100 µL of IL-
6 conjugate was added to each well. The samples were again covered and incubated for 1 h at 
room temperature. Aspiration and washing was again performed 5 times. 100 µL of enzyme 
solution (Pre-titrated Avidin-HRP) was added to each well. The samples were again covered and 
incubated for 30 minutes at room temperature. Aspiration and washing was again performed 7 
times. 100 µL of substrate solution was added to each well. The samples were then covered and 
incubated at room temperature for 15 minutes and protected from light. 50 µL of stop solution 
was added to each well and gently agitated until uniform color was obtained. Absorbances were 
read using a microplate reader ELx808 (BioTek). The plate was read at a 450 nm wavelength and 
corrected for optical imperfections using 570 nm wavelength readings subtracted from the 450 
readings. All readings were completed within 30 minutes of the addition of the stop solution. 
Standard calibration curves were generated using computer software and a regression 
analysis. Concentrations were then calculated and expressed as total weight of molecules by 
picograms/milliliter (pg/ml) for IL-6.  For each experiment, means and standard deviations were 
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calculated and statistical significance between groups was analyzed. The minimum detectable 
concentration for the ELISA was less than 0 pg/mL and the maximum detectable concentration 
was 45,635.75 pg/mL. All samples were analyzed separately and in duplicate. The standard curve 
was used to estimate the concentration of each sample. If a sample tested at a level lower than the 
minimum detectable concentration, it was reported as 0 pg/mL.  
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Figure 7 ELISA samples demonstrating IL-6 identification  
  
Figure Legend:  a) Samples placed in wells. b) Samples and standards after substrate was 
added c) Samples and standards after stop solution.  
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Analysis of IL-6 expression in PRF membrane:  
In an effort to minimize error, the release of IL-6 from the PRF membrane itself was 
analyzed. After fabrication, the membrane itself was separated into 12 pieces approximately 0.5 
cm x 0.5 cm and placed in ELISA well plates. From another membrane, liquid was expressed 
immediately after fabrication and pipetted into 12 wells and the ELISA performed to analyze PRF 
independent release of IL-6 so that any background release by the membrane could be considered 
in group analysis.  
Statistical analysis 
Before initiation of the study, a power analysis was completed. Based on previous 
studies, it was anticipated that 50% of control teeth would be classified as vital and 79% of test 
teeth would be classified as vital. Using these criteria, power analyses were performed, and a 
proposed sample size of 20 patients with 4 teeth each (80 teeth) was determined. We expected 20 
subjects to enroll in the study, with 4 reimplanted teeth per person, 2 PRF and 2 control teeth 
(giving a total of 80 teeth, 40 randomized to PRF and 40 randomized to control). With 80 teeth 
we can detect a difference of 32% in vitality (82% vitality in the PRF group vs. 50% vitality in 
the control group) with 90% power and an alpha level of 0.05. The test statistic used for the 
power calculation is the two-sided Z test (unpooled). The sample size calculation was performed 
using NCSS and PASS. 
Patient characteristics were tabulated using frequencies and percentages for categorical 
variables and median and range for age. Linear mixed models were used to look at the effect of 
treatment on EPT pre-treatment, post-treatment and at changes over time. Compound symmetry 
structure was used for the covariance matrix, based on Akaike information criteria. This model 
allows for correlation due to multiple teeth examined in each person. Generalized linear mixed 
models (GLMM) were used to look at the proportion positive for thermal and percussion tests as 
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outcome variables both pre-treatment, post-treatment and at changes over time.  For the models 
considering treatment and time, interactions were considered. Multivariate models were also 
examined looking at the treatment effect after adjusting for age, gender, race, smoking status, 
diabetes and duration of treatment. SAS software version 9.3 was used for statistical analysis 
(SAS Institute Inc., Cary, NC). 
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CHAPTER 4: RESULTS 
Clinical Trial: 
Patient characteristics: 
A total of 18 subjects were enrolled in the study with a total number of 70 teeth. One 
tooth was lost to the study due to the need for early extraction for patient comfort. The median 
number of treated teeth per person is 4 and ranged from 2 to 6. Half of the teeth were randomized 
via coin flip to PRF treatment and half to no PRF treatment. To prevent imbalances between 
treatment groups and improve the power for the small sample size, patient stratified 
randomization was utilized. Patients were followed for a minimum of 3 months and a maximum 
of 11 months. Throughout the treatment period, 5 out of 18 patients (28%) required a single post-
operative week of clindamycin (300 mg taken three times daily for 7 days) upon presenting with 
signs of infection. During the course of the study one patient reported an increased HBA1c from 
previously under 8 (in accordance to inclusion requirements) to 10.7. It was decided to not 
exclude this patient from the study, but to include this in the statistical considerations. Patient 
characteristics are shown in Table 3 below.   
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Table 3: Patient characteristics at baseline  
 
There was no statistical significance between groups for baseline diagnostic tests 
including EPT, thermal, and percussion. Table 4 depicts the mean diagnostic tests for both the 
control and test groups.  
Table 4: Pre-treatment tooth characteristics 
  
Clinical outcomes: 
 There was no statistically significant difference between groups for any of the vitality 
readings post operatively. EPT, thermal, and percussion means per group are depicted in Table 5. 
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Table 5: Post-treatment tooth characteristics 
 
During the initial intervention PRF treated teeth were out of the mouth for a longer 
amount of time in comparison to the control teeth and this difference in out of mouth time was 
statistically significant (p=0.035). Table 6 shows the mean out-of-mouth time and its statistical 
significance.  
Table 6: Out of mouth time per treatment group  
 
Diagnostic test: EPT 
Changes in EPT over time (pre vs post) were evaluated by treatment group, using a linear 
mixed effects model. There was not a significant interaction between treatment and time (p=0.86) 
indicating that the effect of treatment did not differ over time. It was also noted that on average 
EPT did not differ by treatment vs. control (p=0.56). Both groups saw a significant increase in 
EPT from pre- to post-treatment (p<0.0001). On average, the post-treatment EPT is 22.7 higher 
than the pre-treatment EPT. Table 7 shows the diagnostic EPT values for both groups and Figure 
8 depicts these changes.  
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Table 7: Changes in EPT over time 
 
Figure 8: Changes in EPT over time by group 
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A multivariate model of changes in EPT over time was utilized. Again, interactions 
between treatment and time were not significant; therefore, it was excluded from the model. As 
seen in Table 8, the multivariate model showed females have lower levels of EPT on average by 
16.7, and a significant increase in EPT over time. The interaction between treatment and time out 
of the mouth was not significant (p=0.11). Time out of the mouth significantly increases EPT on 
average by 6.1 (p=0.008). 
Table 8: Multivariate model of changes in EPT over time.  
 
Diagnostic test: thermal 
Changes in thermal over time (pre vs post) by treatment group were evaluated, using a 
GLMM. The link function was legit, but results were backtransformed to the original scale and 
can be interpreted as proportion positive. Show in Table 9 and depicted by Figure 9, there was not 
a significant interaction between treatment and time (p=0.45) indicating that the effect of 
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treatment on thermal did not differ over time. It was also noted that on average, thermal did not 
differ by treatment vs. control (p=0.30). Both groups saw a significant decrease in proportion 
positive for thermal from pre- to post-treatment (p=0.014). On average the post-treatment thermal 
proportion is 0.30 lower than the pre-treatment proportion. 
Table 9 Changes in thermal over time 
 
Figure 9 Changes in thermal over time by group 
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A multivariate model of changes in thermal over time was then evaluated, represented in 
Table 10, here on the logit scale. Again, interactions between treatment and time were not 
significant, therefore it was excluded from the model. Again, time out of mouth was found to be a 
statistically significant variable (p= 0.039). Proportional thermal change was significant over 
time, and decreases with time out of the mouth. 
Table 10: Multivariate model of changes in Thermal over time (data on the logit scale)  
 
Diagnostic test: percussion 
Next, changes in percussion over time (pre vs post) by treatment group were looked at 
using a generalized linear mixed effects model. The link function was logit, but results were 
back-transformed to the original scale and can be interpreted as proportion positive. Percussion 
did not differ significantly over time or by treatment as can be seen by Table 11 and depicted by 
Figure 10. 
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Table 11. Changes in percussion over time 
 
Figure 10. Changes in percussion proportion positive over time by group 
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A multivariate model of changes in percussion over time was then performed, here on the 
logit scale. Again, interactions between treatment and time were not significant; therefore, it was 
excluded from the model. Percussion did not differ significantly by any of the study variables as 
seen in Table 12. 
Table 12: Multivariate model of changes in percussion over time (data on the logit scale) 
 
Histological outcomes: 
Comparison of histological grading:  
After removing teeth that were determined to be inconclusive histologically, histology 
data was available on 62 teeth. There was no statistically significant difference between PRF and 
the control group for inflammatory type, grade, evidence of vitality (nuclei in pulpal tissue), or 
presence of blood vessels. Table 13 has basic chi-square tests at the tooth level demonstrating 
these results. 
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Table 13. Post-treatment tooth characteristics – histology (at the tooth level) 
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Next, the multivariate model GLMM was utilized to evaluate evidence of vitality. Table 
14 presents odds ratios (OR) and 95% confidence intervals. Vitality was not associated with any 
patient characteristics. Older age was marginally associated with evidence of vitality 
Table 14: Multivariate model of evidence of vitality 
 
The following section includes the descriptive histology that was observed for the healthy 
control teeth not involved in the study, teeth not receiving PRF (the control group), and teeth 
receiving PRF (the test group).  
 Healthy control teeth from patients not receiving study interventions: 
The vessels were primarily centrally located and ran in a longitudinal direction from the 
enlarged apical foramina to the coronal pulp chamber. A well-vascularized, cell-rich connective 
tissue was observed in the apical areas of the pulp chambers. The larger blood vessels were 
centrally located and surrounded by smaller intermediate sized vessels. Histologically, a normal 
pulp tissue with a regular odontoblastic layer was observed. 
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Figure 11: Example of vital pulp from a healthy freshly extracted tooth not having received 
study interventions (10x) 
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Descriptive histological results for teeth without PRF (Control) and teeth with PRF (test):   
There were teeth that exhibited signs of vitality and teeth that were apparently necrotic in 
both groups. The teeth that appeared to be necrotic exhibited significantly less signs of normal 
vital pulp including a generalized lack of vascularity, less organization of pulpal tissue, 
disorganized collagen, tissue without apparent nuclei, and a greater inflammatory infiltrate. Some 
tissues were either poorly stained or so minimal in quantity that it was not discernable. 
Frequently, only fragments of cells and necrotic collagen were found. When an infiltrate was 
observed, the majority of teeth exhibited an extensive neutrophilic presence with occasional signs 
of chronic inflammation distinguishable by the presence of plasma cells and lymphocytes.  
The teeth that were determined to be vital had the following characteristics. These teeth 
were seen to generally have more organized collagen throughout the chamber with vitality 
evident through the presence of cellular nuclei. Areas of vascularization were mostly located in 
the apical region of the pulp canal for the majority of teeth; however, in many teeth the blood 
vessels had proliferated throughout the pulp chamber. The area of vascularized pulp tissue varied 
in size depending on the tooth. When blood vessels were observed in the chamber, they 
resembled the control teeth examined prior to the study. The vessels were usually primarily 
centrally located and ran in a longitudinal direction from the apical foramina to the coronal pulp 
chamber. A well-vascularized, cell-rich connective tissue was observed throughout the pulp 
chambers. The larger blood vessels were centrally located and surrounded by smaller 
intermediate sized vessels. Histologically, a normal pulp tissue with a regular odontoblastic layer 
was usually observed. In some cases, a mild infiltrate was observed. In teeth that were determined 
to be vital, there was most frequently either no infiltrate or acute inflammation distinguishable by 
neutrophils. Figures 12 and 13 depict the variety of histological that were observed with both 
control and test teeth respectively.  
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Figure 12: Histological images of teeth not treated with PRF (Control) representative of 
sample of n=34 
 
 
 
 
 
 
 
Figure Legend:  a) Control tooth demonstrating pulp stones and blood vessels in a specimen 
present in the mouth for 3 months (10x). b) Control tooth demonstrating blood vessels in a 
specimen present in the mouth for 3 months (10x). c) Control tooth demonstrating blood 
vessels, nuclei, and local infiltrate, in a specimen present in the mouth for 3 months (10x). d) 
Control tooth demonstrating blood vessels, nuclei, and pulp stones in a specimen present in the 
mouth for 3 months (10x). 
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Figure 13: Histological images of teeth treated with PRF (Test) representative of sample of 
n=35 
 
 
 
 
 
 
 
 
 
 
Figure Legend:  a) Test tooth demonstrating vital pulp tissue in a specimen present in the 
mouth for 3 months (40x). b) Test tooth demonstrating endothelial lined blood vessels in 
a specimen present in the mouth for 11 months (20x). c) Test tooth demonstrating vital 
blood vessels in the pulp chamber of a specimen present in the mouth for 5 months (10x). 
d) Test tooth demonstrating vital blood vessels in the pulp chamber of a specimen present 
in the mouth for 5 months (40x).  e) Test tooth demonstrating necrotic pulpal debris of a 
specimen present in the mouth after 4 months (5x).  
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Statistical analysis of histological results and clinical diagnostic tests: 
Again a univariate GLMM model was utilized to evaluate evidence of vitality, looking at 
associations with pre diagnostic tests and vitality. Vitality was associated with Pre EPT but not 
with any other variable prior to the study. A one-unit increase in EPT is 5% more likely to have 
evidence of vitality (p=0.054).  
Table 15: Evidence of vitality based on pre-diagnostic tests 
 
Lastly, the univariate GLMM model was again utilized while looking at the associations 
with post diagnostic tests and vitality. Vitality was not associated with post diagnostic tests. 
Table 16: Evidence of vitality based on post-diagnostic tests 
 
In vitro analysis of IL-6 and PRF outcomes:  
ELISA results between groups Group A (PDL+PRF), Group B (PDL + LPS +PRF), 
Group C (PDL + LPS), and Group D (PDL only), at three time points. Table 17 expresses the 
means and standard deviations of each group at time points 24, 48, and 72h. 
 
 
54 
 
   
Table 17: ELISA data in pg/ml of IL-6  
 
At 24 hours there is an overall significant difference between the groups by Kruskal-Wallis 
test (p=0.0004). Wilcoxon rank sum test was used to conduct pairwise comparisons. Table 18 
contains the pairwise comparison p-values between the groups at 24 h, adjusted for pairwise 
comparisons with Bonferroni’s method. The high standard deviation for Group A is likely due to 
laboratory error. Figure 14 graphically represents these comparisons.  
 PDLs concentration is significantly lower than the group with LPS+PRF and the LPS 
only group.  
 The LPS only group concentration is significantly different (lower) than the group with 
LPS+PRF 
Table 18:  24-hour culture group IL-6 production comparison 
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Figure 14: 24-hour mean pg/ml concentrations PDL cells   
 
 
 
At 48 hours there is an overall significant difference between the groups by Kruskal-Wallis 
test (p=0.0003). Wilcoxon rank sum test was used to conduct pairwise comparisons. Table 19 
contains the pairwise comparison p-values between the groups at 48 h, adjusted for pairwise 
comparisons with Bonferroni’s method. Figure 15 graphically represents these comparisons. 
 The PDLs concentration is significantly lower than all other groups 
 The LPS only group concentration is significantly different (lower) than the LPS+PRF 
group.  
 The PRF only group concentration is significantly different (lower) than LPS+PRF 
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Figure legend: Same number of * indicates no difference between groups. 
Different number of * indicates statistical significance between groups. 
Between PDL+LPS+PRF and PDL+LPS (p<0.031). Between PDL+LPS+PRF 
and PDL (p<0.03). Between PDL+LPS and PDL (p<0.03).  
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Table 19: 48-hour culture group IL-6 production comparison 
 
Figure 15: 48-hour mean pg/ml concentrations PDL cells   
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Figure legend: Same number of * indicates no difference between groups. 
Different number of * indicates statistical significance between groups. 
Between PDL+LPS+PRF and PDL+PRF (p<0.049) and PDL and PDL+LPS 
(p<0.031). Between PDL+PRF and PDL (p<0.049). Between PDL + LPS and 
PDL (p<0.031).  
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At 72 hours there is an overall significant difference between the groups by Kruskal-Wallis 
test (p=0.0006). Wilcoxon rank sum test was used to conduct pairwise comparisons. Table 20 
contains the pairwise comparison p-values between the groups at 72 h, adjusted for pairwise 
comparisons with Bonferroni’s method. Figure 16 graphically represents these comparisons. 
 The LPS+PRF group concentration is significantly different (higher) than all other 
groups.  
Table 20: 72-hour culture group IL-6 production comparison 
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Figure 16: 72-hour mean pg/ml concentrations PDL cells 
 
 
 
The averages over time show an overall significant difference between the groups by 
Kruskal-Wallis test (p<0.0001). Wilcoxon rank sum test was used to conduct pairwise 
comparisons. Table 21 contains the pairwise comparison p-values between the groups, adjusted 
for pairwise comparisons with Bonferroni’s method. Figure 17 graphically represents these 
comparisons. 
 All groups are significantly different from each other, except for the groups with only 
PRF and only LPS. 
  
Figure legend: Same number of * indicates no difference between groups. 
Different number of * indicates statistical significance between groups. 
Between PDL+LPS+PRF and PDL+PRF and PDL (p<0.049). Between 
PDL+LPS+PRF and PDL+LPS (p<0.031). 
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Table 21: Average 24-72 hour culture group IL-6 production comparison 
 
Figure 17: Average pg/ml of IL-6 from 24-72 hours 
 
 
 
Evaluating each individual group’s change over time showed that the PRF only group 
did not statistically change over time (p=0.83) by using the Kruskal-Wallis test. The LPS+PRF 
group also did not significantly change over time (p=0.13). The LPS only group decreased over 
time (p=0.0011), and the PDLs increased over time (p=0.0017). Figure 18 graphically depicts 
these group comparisons.  
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Figure 18: Averages of groups in pg/ml of IL-6 over 24-72 hours 
 
Evaluation of the PRF membrane and expressed liquid revealed that IL-6 release 
within 24 h of membrane preparation was negligible and therefore, did not interfere with group 
concentrations.   
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Figure legend: The PRF only group and the LPS+ PRF groups did not significantly change over time. The 
LPS only group decreased over time. The PDLs increased over time. The * indicates a statistically 
significant change between the 24-72 hour periods.  
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CHAPTER 5: DISCUSSION 
This single-blinded randomized controlled clinical trial evaluated the effect of PRF on 
pulp vitality after atraumatic extraction, root resection, and immediate reimplantation for a period 
of 3-11 months. Every precaution was taken to eliminate any bias by compartmentalizing the 
various aspects of the study protocol as follows: blind examiner (EE) collected baseline and final 
diagnostic data, fabricated PRF, performed the root resection, and recorded histological results 
dictated by pathologist. Clinician (JB) performed extractions and randomization of PRF 
application, but was blind to diagnostic data and histological findings until study completion. 
Investigator (PG) evaluated histological specimens while blind to any patient information, 
diagnostic data, or tooth treatment. While patient selection, and furthermore tooth selection 
within those patients, was severely limited by the poor condition of their oral health, teeth were 
selected that permitted little to no baseline differences between treatment groups. These 
differences resulted in no statistical significance in baseline parameters. Pre EPT values were 
33.1 (+/- 3.0) and 34.0 (+/- 3.0) for control and PRF teeth respectively. Pre thermal values 
demonstrated that 93.9% (+/- 4.8) of control and 85.2% (+/- 8.9) of PRF treated teeth responded 
positively to cold. During the study, 28% of patients required a post-operative week of 
clindamycin due to symptoms of infection; however, the multivariate analysis did not find any 
correlation between any other variable.     
We found that the addition of PRF did not significantly impact any measured variable when 
compared to the non-PRF controls. There are numerous points to consider while interpreting 
these results. Firstly, vitality of control teeth was not an unexpected outcome. In Skoglund’s 
research, the series of studies showed that if an apicoectomy procedure is used to enlarge the 
apical foramen, revascularization of mature teeth after transplantation is possible and has a high 
success rate. Therefore, the intention of the present study was to evaluate if PRF enhanced these 
results in mature teeth. The present study showed similar histological results for both groups as 
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did the apicoectomy histology of the Skoglund series, emphasizing that enlargement of the apical 
foramen may be enough to encourage regeneration. An additional finding in the Skoglund series 
suggests a possible reasoning for the decreasing trend in vitality parameters observed in the 
present study. Skoglund et al. (1981) discussed that widening of the apical foramen with a bur is 
not as successful as the method they chose in their study, which was enlargement with a wire 
cutter. As the methods in the present study involved a bur for the apicoectomy, it is possible that 
this encouraged more inflammatory response than the wire cutter in Skoglund’s study. This may 
be one reason why both groups saw a significant increase in EPT (average of 22.7 EPT points 
higher post-treatment) and decrease in thermal response (30% lower) from pre to post vitality 
recordings.   
Next, a discussion on subject complications is necessary. Subject recruitment proved to be 
challenging due to the specific requirements of the study and the general nature of the dentition of 
many patients presenting to the dental school in need of full or partial dentures. Therefore, the 
original N of 20 subjects with 80 study teeth was not attainable in the restricted time for the 
study. Instead, an N of 18 subjects with 69 teeth were evaluated. This 14% reduction may have 
kept some of the measurement parameters from achieving statistical significance. Additionally, 7 
of these teeth were determined ‘inconclusive’ histologically and could not be utilized for 
histological evaluation.  
Next, one must consider the state of the teeth and periodontium of the subjects in this study. 
Autotransplantation can be highly successful especially in teeth without fully developed roots 
(ideally no more than two thirds of its final length) and if it is moved atraumatically to a suitable 
receptor site with minimal out-of-mouth time. The receptor site should be wide enough and free 
of inflammation to enhance results (Laureys et al., 2013). In the present study, due to the limited 
patient pool as well as the nature of the dentition in most patients electing full dentures, the teeth 
and corresponding periodontium were not ideal. Laureys et al. (2013) notes that absence of 
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inflammation can improve the results of autotransplantation; however, most of the subjects in the 
present study had significant inflammation, minor to severe carious lesions, significant occlusal 
wear, and periodontal disease limiting the support for the reimplanted teeth.  
In addition to the initial substandard condition of the subjects’ dentition, it became apparent 
that in many cases the state of occlusion would be impossible to manage.  During the healing 
process, it is important that the tooth is not traumatized as occlusal forces can expand the 
inflammatory response and lead to fibrous tissue formation in the pulp tissue (Hasegawa et al., 
2007). This could be a contributing factor in some subjects whose teeth maintained less vitality 
than others. As these patients were undergoing the process of denture fabrication, many of them 
were in a state of considerable malocclusion and had few remaining teeth; therefore, attempts 
were made to minimize occlusal discrepancies but ideal was not always achievable. In many 
cases due to loss of vertical dimension, malocclusion, or limited remaining teeth for mastication, 
the subjects continued to function on the study teeth and the teeth were unable to be removed 
from traumatic occlusion.  
A second occlusal issue that arose was patients with nocturnal parafunctional habits such as 
bruxing and clenching. It was observed that these patients experienced considerably more post-
operative discomfort than other study patients, and likely resulted in more trauma to the study 
teeth throughout the observation period. The results from the histological analysis further pointed 
to the importance of minimal occlusal trauma. Many of the individuals who had more than one 
non-vital tooth (either control or test) at the end of the study were patients that presented with 
multiple post-operative complications due to nocturnal parafunctional habits. One individual had 
six teeth that were utilized for the study and all six, regardless of treatment, responded non-vital 
to diagnostic testing and were all observed to be necrotic histologically. This individual had the 
most post-operative appointments and reported significant pain while sleeping and had a history 
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of bruxing and clenching. Additionally, patients that had only one arch of dentition remaining, 
therefore no opposing dentition, were observed to have fewer complications throughout the study.  
A factor found to be more critical than the application of the PRF was the amount of time it 
took to complete the intervention to the tooth and therefore, the amount of time the tooth was out 
of the mouth. In this study, the average out of mouth time for control teeth and PRF treated teeth 
was 1.62 (+/-.11) and 1.88 (+/- .11) minutes respectively; this was statistically significant (p= 
0.035). Out-of-mouth time is another important feature to consider in the success of the 
reimplantation (Andreason et al., 1981; Andreason et al., 1990). The out-of-mouth time should be 
kept at a minimum through quick handling and efficient execution of the procedure steps 
(Laureys et al., 2013). In the present study, the out-of-mouth time was longer for teeth receiving 
the intervention. This resulted in a statistically significant relationship with post EPT (p=.0090) 
and thermal values (p=.0039).  Better results for PRF treated teeth may have been observed if 
out-of-mouth time for PRF treated teeth and control teeth had been similar. When investigating 
pulpal revascularization and vitality, it may benefit future studies to focus more on the out of 
mouth time for tooth transplantations than on the different interventions to the root surface.  
In addition, there was also subject bias that came into play regarding the accuracy of the 
results. Due to the nature of the diagnostic testing it is difficult to determine a simple yes or no 
vitality reading. Percussion is suggestive of pressure in the PDL or possibly traumatic occlusion, 
but does not give a clear answer regarding vitality. Thermal testing can be misleading as many 
individuals have vital teeth that all test negative to cold. EPT can allow the investigator to 
evaluate trends, but it is difficult to determine complete loss of vitality. Additionally, with 
regeneration, vitality diagnostic testing is not always predictable. Peters (2014) noted that it is 
unlikely there will be a positive response to cold or electrical stimuli in all cases of regeneration. 
This was verified histologically, as there was no correlation found between post-operative 
diagnostic testing and histological evidence of vitality; however, there was a correlation with pre- 
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diagnostic EPT tests (p=0.054). This suggests that teeth with high EPT values to start with had a 
higher chance of being vital at the end of the study. This was difficult to evaluate; however, as 
subjects were frequently not consistent in when they informed the investigator (EE) they felt the 
stimulus. For example, sometimes they would inform upon experiencing any response to stimulus 
and then would not respond unless it was to a certain ‘strength’ or ‘discomfort’ level they were 
expecting. It also became apparent that subjects may be withholding honest answers in efforts to 
sway the results in one direction or the other. Even though investigators did not inform the 
subjects on what responses were positive or negative, it was apparent to the investigator that some 
desired a successful result and tried to provide that. This may have led to some bias in reporting 
the diagnostic test results, therefore, it is crucial that histology was also available for examination.  
For these reasons, it was beneficial that the study additionally included evaluation of the 
histological state of each study tooth. Some difficulties were encountered in this aspect of the 
study as well. As many of the teeth were not in ideal condition and many were small mandibular 
incisors, it was frequently difficult to obtain a clean view of the pulp chamber. If pulp tissue was 
not seen on initial cuts, recuts requesting deeper sections were ordered. After multiple recuts and 
sometimes reorientation of the teeth, the pulp chambers could still not be found. This led to 7 
teeth (10% of samples) being labeled as inconclusive and histological data could not be submitted 
for statistical analysis on these teeth. From the histological patterns noted, it appears that repair of 
the pulp occurs through the proliferation and migration of cells from the recipient bed in the 
periapical region and moves upward towards the coronal aspect of the pulp canal. This is in 
accordance with other autotransplantation studies (Skoglund et al., 1998; Laureys et al., 2010). 
Despite the teeth having been in the mouth for a period of at least 3 months, if there was 
inflammatory infiltrate present it was frequently observed as acute or mixed (52% of samples). 
This may have been related to the IL-6 present in the PRF membrane; given that IL-6 extends the 
period of acute inflammation before finally assisting in the transition to chronic inflammation 
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(Gabay et al., 1997). While 40% of the samples presented with no observable inflammatory 
infiltrate and only 8% demonstrated chronic inflammation, it is plausible that the PRF was aiding 
in prolonging the acute inflammatory response. As the PRF was placed based off of a coin flip, 
the teeth receiving the PRF may not have been very far apart and therefore, the benefits of the 
PRF may have extended to the control teeth which is why no observable difference was noted 
between groups for either diagnostic testing or histological analysis of regeneration. A split 
mouth design may not be reasonable when utilizing a material with the potential to measurably 
affect the inflammatory response so drastically. It is unlikely it remained localized to only the 
tooth apex to which it was applied. Regardless, after evaluation of both the diagnostic test results 
as well as the histologic data, the initial clinical hypothesis must be rejected. Ultimately, PRF did 
not enhance the regeneration of teeth in the treatment group over the control group.  
Regarding the IL-6 in vitro results, it was observed that in contrast to the initial 
hypothesis, PRF synergized with LPS in stimulation of IL-6 from human PDL cells. A one-way 
analysis of variance (ANOVA) test was conducted. An ANOVA has 4 assumptions: 
independence, normality, linearity, and equal variance between groups. Because model 
assumptions were violated with the in vitro data (normality and equal variance) and 
transformations did not fix the violations, non-parametric tests were used for comparisons. 
Analysis was done of the data at each time point and for all the time points combined. A Kruskal-
Wallis test was used to look at overall group differences. Pairwise comparisons were conducted 
with the Wilcoxon rank sum test and were adjusted for multiple comparisons using Bonferroni’s 
method. SAS software version 9.3 was used for statistical analysis (SAS Institute Inc., Cary, NC). 
Throughout the experiment from 24-72 h, the PRF+LPS group maintained a statistically 
significant (p<.001) higher concentration of IL-6 when compared to all other groups. The PRF 
only group behaved essentially like the LPS only group and demonstrated no statistical 
significance throughout the observed time period indicating that PRF and LPS are similar in their 
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abilities to stimulate the production of IL-6 from PDL cells in culture. Several considerations 
must be taken into account in interpreting these results. Firstly, PRF liquid contained negligible 
IL-6, which is in accordance with published literature on initial cytokine release from a PRF 
membrane (Dohan et al., 2009). Dohan et al. (2009), demonstrated that the initial extracted 
amounts of growth factors soon after membrane preparation was always significantly lower than 
the released total amounts from the membrane itself when tested after 7 days of incubation. 
Therefore, through determining the initial release of IL-6 from the PRF membrane to be 
negligible, it can be inferred that the IL-6 expression observed in the present study is a product of 
stimulation from the PDL cells in culture.  
While there was no IL-6 detectable after 24 h in the PRF membrane or the liquid 
immediately expressed from the membrane, it is plausible that there may have been additional 
release over an extended period of time. In a study by Dohan et al. (2009), PRF membranes and 
the liquid expressed from them shortly after fabrication were analyzed for 4 main cytokines via 
ELISA. Over 200 h, cytokines TGFβ1, VEGF, PDGF-AB, and TSP-1 were evaluated in time 
intervals, and all but VEGF demonstrated similar release patterns with a quick release during the 
first 24 h and then a slow down around day 2 and finally a steady state of slow release up until 
day 5. VEGF showed an increased release during the initial 4 h and then followed the trends of 
the others. This demonstrates that PRF does release cytokines into the environment, even without 
provocation.  
From the results of the present study it is evident that IL-6 does not follow a similar quick 
24-hour release; however, we do see a similar trend (though not statistically significant) in the 
amount of IL-6 expressed by PDL cells at 24-72 h suggesting that the pro-inflammatory cytokines 
released from the PRF membrane evokes IL-6 production by the PDLs which peaks early on and 
then holds a relatively steady state with minor decline over the next two days. This demonstrates 
the known slow steady release of cytokines previously shown with PRF; had the study been 
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extended, there may have been a larger drop observed later.  In a study by Su et al. (2009), the 
growth factor concentrations of PRF were analyzed and shown to increase in concentration in 
solution from 5 to 300 minutes. While the investigators did not analyze IL-6, it is plausible that 
its expression from the PRF membrane also increases over time. This slow sustained release of 
IL-6 and other pro-inflammatory cytokines evoking IL-6 release is a plausible reason for the 
observed increase in this cytokine over the course of 72 h in the present study. When considering 
an in vivo model, this may become an active player between 1-2 weeks after application. If the 
period of study had been extended, a continued decreasing trend in the production may have been 
observed. 
Additional considerations for these results must include a discussion on the quantity of 
IL-6 observed in the laboratory environment versus the differences in the biological environment 
of the human mouth. Dohan et al. (2009) states that immediately after application of PRF, the 
platelets are activated and drastically evoke cytokine and growth factor release from neighboring 
cells during the first few hours after application. It is likely that the time frame of the current 
study captured this massive release of cytokines that elicited IL-6 production from the PDL cells, 
which initially ramped up cell inflammation but then began to taper off, and likely a steady state 
would have been reached. In the present study’s closed system, this trend is straightforward; 
however, when utilized in a human body the multifactorial nature of these interactions become 
complicated. One such consideration involves the leukocyte concentration of the PRF. 
Choukroun’s PRF is a leukocyte-rich form of PRF, meaning that leukocytes are not separated out 
during the fabrication process. The presence of leukocytes in the formulation has been suggested 
to influence the observed pro-inflammatory effects through the proteases and acid hydrolases 
contained in white blood cells (Anitua et al., 2007). This factor also may have perpetuated the 
release of IL-6 in the closed PDL cell environment in the present study; however, the leukocytes 
may have added many additional benefits that outweigh their pro-inflammatory characteristics in 
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an in vivo model. The presence of these leukocytes may have assisted in resolving the 
inflammation for the 40% of teeth that histologically demonstrated no inflammatory infiltrate.  
It has to be acknowledged that the behavior of the leukocytes and the PRF membrane 
itself in a less diluted medium may also be different. Dohan et al. (2009) points out that by 
placing the PRF membranes in DMEM, it creates a massive call for cytokine release due to 
dilution related concentrations. Therefore, it is possible that in a physiological situation, the actual 
release profile in the biological environment may differ. In addition to this, aside from the actual 
cytokine release, one must also consider how the biological environment may respond to other 
components of the PRF fibrin mesh. Hotwani & Sharma (2014) indicate that there are several 
cytokines within the PRF matrix that modulate inflammation and act as anti-inflammatory 
counterparts to the pro-inflammatory cytokines present. IL-4, for example, assists in reducing 
inflammation through decreasing the production of cells that are major players in tissue 
destruction and propagation of the inflammatory response. Simonpiere et al. (2009) note that 
platelet cytokines PDGF, TGF-α, IGF-1 are gradually released as the fibrin matrix is resorbed, 
which allows a perpetual process of healing through neoangiogenesis and the formation of 
connective tissue components. Therefore, the nature of the inflammatory process and the 
complexity of the interactions occurring in vivo must be taken into account when interpreting the 
synergistic effect of PRF and LPS on IL-6 release.  
A certain amount of inflammation is necessary and required for the healing process, 
therefore some stimulation of IL-6 by PRF can actually be a benefit in a biological environment. 
The anti-inflammatory properties of IL-6 can assist in extending the acute inflammatory period 
(Barnes et al., 2011). This, along with other anti-inflammatory cytokines released from PRF, may 
assist in vivo in reducing the tissue destruction during remodeling after tooth avulsion or 
transplantation. Additionally, the angiogenic properties of IL-6 through stimulation of VEGF 
from fibroblasts, as well as prevention of collagenolysis through the upregulation of TIMP-1, 
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may make IL-6 a valuable presence for the promotion of tissue healing (Mihara et al., 1995; Jones 
et al., 2005). Therefore, when considering both the beneficial aspects of IL-6 along with the PRF 
membrane’s release of anti-inflammatory cytokines and ability to evoke other anti-inflammatory 
modulators from cells in the surrounding tissues, the other components within the membrane may 
counteract this seemingly large amount of IL-6 evoked by PRF and LPS in this study. IL-6 may 
have been a benefit in this present study’s clinical arm where it may have helped to prolong the 
acute inflammatory response for all teeth in the area, both test and control, as well as promote 
new vessel growth and regeneration.  
Therefore, from the results of the present study, it is apparent that the initial hypothesis 
must be rejected. Rather than reducing the inflammatory response, it can be concluded that PRF 
unequivocally elicits stimulation of IL-6 from PDL cells. Taking the previously mentioned 
factors into consideration it is likely that IL-6 concentrations in this cell culture study are inflated 
from what may actually be occurring when a PRF membrane is utilized by a dentist to promote 
intraoral healing or by a physician to overcome a patient’s chronic non-healing ulcer.  
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CHAPTER 6: CONCLUSIONS 
 The addition of PRF does not improve the diagnostic tests (EPT, thermal, or percussion) 
or the histological evidence of vitality of an autotransplanted tooth when compared to 
apicoectomy and foramen enlargement alone. However, more benefit may be seen with the use of 
PRF in cases where trauma from occlusion can be ideally managed. Future studies may benefit 
from evaluating the effects of out of mouth time in regards to autotransplanted teeth and vitality 
testing. Additionally, PRF was found to synergistically enhance IL-6 production from PDL cell 
cultures when combined with LPS. The overall effects of this production may be diminished in 
vivo when considering the other anti-inflammatory cytokines produced in response to IL-6. 
Evaluating multiple pro and anti-inflammatory cytokines in the PRF membrane may be beneficial 
for future studies.  
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